James E. Dentzer - 10 Sep 2024 Form 4 Insider Report for Imunon, Inc. (IMNN)

Reporting relationship: Director
Issuer ticker: IMNN
Reported as of: 10 Sep 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 10 Sep 2024, 16:52:53 UTC
Prior SEC filing: 14 Jun 2024
Next SEC filing: 30 Jan 2025
Source filing: View source filing
Reporting owner signature: /s/ Kimberly Graper, VP of Finance & Controller

Key filing fact

James E. Dentzer filed Form 4 for Imunon, Inc. (IMNN) on 10 Sep 2024.

Key facts

This page summarizes James E. Dentzer's Form 4 filing for Imunon, Inc. (IMNN).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 10 Sep 2024, 16:52.

Change

Previous filing in this sequence was filed on 14 Jun 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

IMNN transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +3,634
Change %: +27%
Price: $0.000000
Shares after: 17,301
Date: 06 Sep 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,634
Exercise price: $1.04
Footnotes: F1, F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents the closing price of Imunon, Inc. Common Stock on the date of grant.

Footnote F2

The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant.

Footnote F3

Option granted in lieu of cash for portion of board fees.